Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Singular Genomics Systems, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 81 | 1 | 66 | −14 |
| Shares | 37.2M | 15.3K | 35.8M | −1.34M (−3.6%) |
| Value | $74.8M | $30.8K | $43.4M | −$31.4M (−42.0%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 26,350 | $32.0K | 0.00% |
| Dimensional Fund Advisors LP | 19,114 | $23.1K | 0.00% |
| Captrust Financial Advisors | 15,300 | $18.5K | 0.00% |
| Advisor Group Holdings, Inc. | 1,200 | $1.45K | 0.00% |
| Harbour Investments, Inc. | 172 | $208 | 0.00% |
Sold out (19)
Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 221,729 | $445.7K |
| Anson Funds Management LP | 169,747 | $341.2K |
| Jane Street Group, LLC | 40,610 | $81.6K |
| MetLife Investment Management | 34,353 | $69.0K |
| Prelude Capital Management, LLC | 27,700 | $55.7K |
| Tri Locum Partners LP | 16,215 | $33.0K |
| Millennium Management LLC | 15,360 | $31.0K |
| Cubist Systematic Strategies, LLC | 8,321 | $16.7K |
| Metropolitan Life Insurance Co | 4,051 | $8.14K |
| Dark Forest Capital Management LP | 3,980 | $8.00K |
| Point72 Middle East FZE | 1,861 | $3.74K |
| Citigroup Inc | 1,276 | $2.56K |
| TCI Wealth Advisors, Inc. | 472 | $949 |
| New Hampshire Trust | 414 | $832 |
| Glassman Wealth Services | 202 | $406 |
| Credit Suisse AG | 2 | $4 |
| Nisa Investment Advisors, LLC | 90 | $0 |
| Massmutual Trust Co FSB | 135 | $0 |
| Ronald Blue Trust, Inc. | 67 | $0 |
Not filed for Q1 2023 yet (1)
Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Trustcore Financial Services, LLC | 15,300 | $30.8K |